Chemotherapy of Malignant Melanoma

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 1979 Jul 30

PMID 382646

Citations 2

Authors

R S Benjamin

Affiliations

Soon will be listed here.

Citing Articles

The evolution in melanoma treatment as a reflection of precision-oriented medicine.

Kushnir I, Merimsky O Oncol Lett. 2013; 5(2):424-426.

PMID: 23420786 PMC: 3573132. DOI: 10.3892/ol.2012.1065.

Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Amato D, Bruckner H, Guerry 4th D, Ash A, FALKSON G, Borden E Invest New Drugs. 1987; 5(3):293-7.

PMID: 3667165 DOI: 10.1007/BF00175301.

References

Ahmann D, Bisel H, Edmonson J, Hahn R, Eagan R, Oconnell M . Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Clin Pharmacol Ther. 1976; 19(6):821-4. DOI: 10.1002/cpt1976196821. View

Sieper W, Mastrangelo M, Belle R . Phase II study of adriamycin (NSC-123127) in patients with metastatic melanoma. Cancer Chemother Rep. 1975; 59(6):1181-2. View

Cohen S, GREENSPAN E, Ratner L, WEINER M . Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine. Cancer. 1977; 39(1):41-4. DOI: 10.1002/1097-0142(197701)39:1<41::aid-cncr2820390108>3.0.co;2-7. View

Beretta G, Bonadonna G, Cascinelli N, Morabito A, Veronesi U . Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. Cancer Treat Rep. 1976; 60(1):33-40. View

Ahmann D, Hahn R, Bisel H, Eagan R, Edmonson J . Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma. Cancer Chemother Rep. 1975; 59(2 Pt 1):451-3. View

Wittes R, Hong W, Gatchell L, KRAKOFF I, GOLBEY R . Methyl-CCNU in malignant melanoma--a divided dose schedule of administration. Oncology. 1977; 34(1):45-6. DOI: 10.1159/000225178. View

Kleeberg U, Schreml W . [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)]. Dtsch Med Wochenschr. 1976; 101(23):890-4. DOI: 10.1055/s-0028-1104136. View

LUCE J . Chemotherapy of malignant melanoma. Cancer. 1972; 30(6):1604-15. DOI: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5. View

Nordman E, Mantyla M . Treatment of metastatic melanoma with combined 5-fluorouracil and procarbazine. Cancer Treat Rep. 1977; 61(9):1709-10. View

10.

Rodriguez V, Richman S, Benjamin R, Burgess M, Murphy W, Valdivieso M . Phase 2 study with Baker's Antifol in solid tumors. Cancer Res. 1977; 37(4):980-3. View

11.

COSTANZI J . DTIC (NSC-45388) studies in the southwest oncology group. Cancer Treat Rep. 1976; 60(2):189-92. View

12.

Moon J, GAILANI S, Cooper M, Hayes D, Rege V, Blom J . Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma. Cancer. 1975; 35(2):368-71. DOI: 10.1002/1097-0142(197502)35:2<368::aid-cncr2820350211>3.0.co;2-c. View

13.

Cowan D, BERGSAGEL D . Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep. 1971; 55(2):175-81. View

14.

Costanza M, NATHANSON L, Costello W, Wolter J, Brunk S, COLSKY J . Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma. Cancer. 1976; 37(4):1654-9. DOI: 10.1002/1097-0142(197604)37:4<1654::aid-cncr2820370406>3.0.co;2-b. View

15.

Benjamin R, Hall S, Burgess M, WHEELER W, Murphy W, Blumenschein G . A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053). Cancer Treat Rep. 1976; 60(3):289-91. View

16.

Einhorn L, Burgess M, Vallejos C, Bodey Sr G, Gutterman J, Mavligit G . Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res. 1974; 34(8):1995-2004. View

17.

Van Dyk J, FALKSON G . A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. Med Pediatr Oncol. 1975; 1(2):107-11. DOI: 10.1002/mpo.2950010205. View

18.

Aranha G, GRAGE T . Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma. Minn Med. 1977; 60(8):543-8. View

19.

. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C. Biomedicine. 1977; 27(4):158-61. View

20.

Comis R, Carter S . Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev. 1974; 1(4):285-304. DOI: 10.1016/s0305-7372(74)80020-4. View